NYSEAMERICAN:CCEL Cryo-Cell International (CCEL) Stock Price, News & Analysis $4.53 -0.11 (-2.27%) As of 11:12 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Cryo-Cell International Stock (NYSEAMERICAN:CCEL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CCEL alerts:Sign Up Key Stats Today's Range$4.53▼$4.5950-Day Range$3.53▼$5.4052-Week Range$2.72▼$5.45Volume549 shsAverage Volume15,625 shsMarket Capitalization$36.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cryo-Cell International provides stem cell processing and cryogenic storage services, primarily for families preserving cells collected at childbirth. Its core services include processing and storing umbilical cord blood and cord tissue for potential future medical use. Founded in 1989, the company is based in Oldsmar, Florida, and is among the early private cord blood banking businesses in the United States. It serves customers in the U.S. and reaches international markets through distribution relationships. Cryo-Cell has also offered services to preserve stem cells from menstrual blood. Its business centers on collecting, processing and storing biological samples rather than providing medical treatment.AI Generated. May Contain Errors. Read More Cryo-Cell International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks4th Percentile Overall ScoreCCEL MarketRank™: 0.182642314355 of 5 starsCryo-Cell International scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cryo-Cell International. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryo-Cell International is -20.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryo-Cell International is -20.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.25% of the float of Cryo-Cell International has been sold short.Short Interest Ratio / Days to CoverCryo-Cell International has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cryo-Cell International has recently increased by 70.79%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCryo-Cell International does not currently pay a dividend.Dividend GrowthCryo-Cell International does not have a long track record of dividend growth. News and Social Media0.9 / 5News SentimentN/A News SentimentCryo-Cell International has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Cryo-Cell International this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cryo-Cell International insiders have not sold or bought any company stock.Percentage Held by Insiders39.93% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions10.44% of the stock of Cryo-Cell International is held by institutions.Read more about Cryo-Cell International's insider trading history. Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CCEL Stock News HeadlinesGoodyear Tire, Cryo-Cell International and 3 Stocks to Watch Heading Into MondayOctober 12, 2026 | benzinga.comCryo-Cell International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2026October 10, 2026 | marketscreener.comMEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 18 at 1:00 AM | Behind the Markets (Ad)Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial ResultsOctober 9, 2026 | businesswire.comDer aktuelle Kurs der CryoCell International Inc Aktie beträgt 3,5700.August 6, 2026 | de.investing.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial ResultsJuly 15, 2026 | businesswire.comCryo-Cell Receives Acceptance of Compliance Plan From NYSE AmericanMay 8, 2026 | businesswire.comCryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood BanksApril 28, 2026 | finance.yahoo.comSee More Headlines CCEL Stock Analysis - Frequently Asked Questions How have CCEL shares performed this year? Cryo-Cell International's stock was trading at $3.44 at the start of the year. Since then, CCEL stock has increased by 34.6% and is now trading at $4.63. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) released its quarterly earnings data on Friday, October, 9th. The company reported $0.16 earnings per share for the quarter. The business had revenue of $7.82 million for the quarter. How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Advanced Micro Devices (AMD), Walt Disney (DIS), GE Aerospace (GE), Jumia Technologies (JMIA), Netflix (NFLX), NVIDIA (NVDA) and Vertex Pharmaceuticals (VRTX). Company Calendar Last Earnings10/09/2026Today11/18/2026Fiscal Year End11/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CCEL's financial health is in the Green zone, according to TradeSmith. CCEL has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSEAMERICAN:CCEL CIK862692 Webwww.cryo-cell.com Phone(813) 749-2104Fax813-855-4745Employees76Year Founded1989Profitability EPS (Trailing Twelve Months)($1.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.43 million Net Margins-6.25% Pretax Margin-6.13% Return on EquityN/A Return on Assets-3.17% Debt Debt-to-Equity RatioN/A Current Ratio0.86 Quick Ratio0.82 Sales & Book Value Annual Sales$31.57 million Price / Sales1.16 Cash FlowN/A Price / Cash FlowN/A Book Value($2.31) per share Price / Book-1.96Miscellaneous Outstanding Shares8,060,000Free Float4,843,000Market Cap$36.47 million OptionableNot Optionable Beta0.45 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NYSEAMERICAN:CCEL) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersGold Trades Near Record Highs: What It Means for MinersBarrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...Wall Street Logic | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryo-Cell International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.